Accumulation of DNA methylation is associated with tumor stage in gastric cancer - PubMed (original) (raw)
Comparative Study
. 2006 Mar 15;106(6):1250-9.
doi: 10.1002/cncr.21754.
Affiliations
- PMID: 16475210
- DOI: 10.1002/cncr.21754
Free article
Comparative Study
Accumulation of DNA methylation is associated with tumor stage in gastric cancer
Naohide Oue et al. Cancer. 2006.
Free article
Abstract
Background: The authors purpose in this study was to clarify the difference in terms of clinicopathologic features between gastric cancer (GC) with high numbers of DNA methylated genes and CpG island methylator phenotype (CIMP)-positive GC as originally defined.
Methods: We analyzed DNA methylation of 12 tumor-related genes (hMLH1, MGMT, p16(INK4a), CDH1, RAR-beta, HLTF, RIZ1, TM, FLNc, LOX, HRASLS, HAND1) in 75 samples of GC from 75 patients, 25 samples of corresponding nonneoplastic mucosa from 25 patients, and 10 samples of normal gastric mucosa from 10 healthy young individuals by methylation-specific polymerase chain reaction (PCR) and bisulfite PCR. We also investigated CIMP status by examining the methylation of five MINT loci and p53 mutation status by PCR single-strand conformation polymorphism. We measured levels of expression of mRNAs for these 12 genes by quantitative reverse transcription PCR in 50 GC specimens.
Results: The average number of methylated genes per tumor was 4.83. DNA methylation of each gene was correlated with low expression of the respective mRNA. High methylation (GC with 5 or more methylated genes) was detected in 39 (52.0%) of 75 GCs. Twenty-nine (37.8%) of 75 GCs were CIMP-positive. DNA methylation of each of the 12 genes was observed more frequently in the high-methylation group than in the low-methylation group. Methylation of 6 specific genes occurred more frequently in CIMP-positive GC than in CIMP-negative GC. Methylation of the remaining 6 genes was not correlated with CIMP-status. High methylation was found more frequently in Stage III/IV GC (26 of 40 cases, 65.0%) than in Stage I/II GC (13 of 35 cases, 37.1%, P = 0.029).CONCLUSIONS.These findings indicate that GCs with higher numbers of methylated genes have more distinct DNA methylation profiles than the originally defined CIMP-positive GCs. DNA methylation of tumor-related genes accumulates in conjunction with tumor progression.
(c) 2006 American Cancer Society.
Similar articles
- DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
Shutoh M, Oue N, Aung PP, Noguchi T, Kuraoka K, Nakayama H, Kawahara K, Yasui W. Shutoh M, et al. Cancer. 2005 Oct 15;104(8):1609-19. doi: 10.1002/cncr.21392. Cancer. 2005. PMID: 16134180 - CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
Chang MS, Uozaki H, Chong JM, Ushiku T, Sakuma K, Ishikawa S, Hino R, Barua RR, Iwasaki Y, Arai K, Fujii H, Nagai H, Fukayama M. Chang MS, et al. Clin Cancer Res. 2006 May 15;12(10):2995-3002. doi: 10.1158/1078-0432.CCR-05-1601. Clin Cancer Res. 2006. PMID: 16707594 - Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus.
Kusano M, Toyota M, Suzuki H, Akino K, Aoki F, Fujita M, Hosokawa M, Shinomura Y, Imai K, Tokino T. Kusano M, et al. Cancer. 2006 Apr 1;106(7):1467-79. doi: 10.1002/cncr.21789. Cancer. 2006. PMID: 16518809 - Gene methylation in gastric cancer.
Qu Y, Dang S, Hou P. Qu Y, et al. Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10. Clin Chim Acta. 2013. PMID: 23669186 Review. - CpG island methylator phenotypes in aging and cancer.
Toyota M, Issa JP. Toyota M, et al. Semin Cancer Biol. 1999 Oct;9(5):349-57. doi: 10.1006/scbi.1999.0135. Semin Cancer Biol. 1999. PMID: 10547343 Review.
Cited by
- Filamin C, a dysregulated protein in cancer revealed by label-free quantitative proteomic analyses of human gastric cancer cells.
Qiao J, Cui SJ, Xu LL, Chen SJ, Yao J, Jiang YH, Peng G, Fang CY, Yang PY, Liu F. Qiao J, et al. Oncotarget. 2015 Jan 20;6(2):1171-89. doi: 10.18632/oncotarget.2645. Oncotarget. 2015. PMID: 25577646 Free PMC article. - Establishment of a DNA methylation marker to evaluate cancer cell fraction in gastric cancer.
Zong L, Hattori N, Yoda Y, Yamashita S, Takeshima H, Takahashi T, Maeda M, Katai H, Nanjo S, Ando T, Seto Y, Ushijima T. Zong L, et al. Gastric Cancer. 2016 Apr;19(2):361-369. doi: 10.1007/s10120-015-0475-2. Epub 2015 Feb 13. Gastric Cancer. 2016. PMID: 25678126 - Promoter hypermethylation of CDH1, FHIT, MTAP and PLAGL1 in gastric adenocarcinoma in individuals from Northern Brazil.
Leal M, Lima E, Silva P, Assumpção P, Calcagno D, Payão S, Burbano RR, Smith M. Leal M, et al. World J Gastroenterol. 2007 May 14;13(18):2568-74. doi: 10.3748/wjg.v13.i18.2568. World J Gastroenterol. 2007. PMID: 17552003 Free PMC article. - Mixed-type gastric cancer and its association with high-frequency CpG island hypermethylation.
Park SY, Kook MC, Kim YW, Cho NY, Kim TY, Kang GH. Park SY, et al. Virchows Arch. 2010 Jun;456(6):625-33. doi: 10.1007/s00428-010-0916-6. Epub 2010 Apr 27. Virchows Arch. 2010. PMID: 20422213 - Association Between hMLH1 Promoter Methylation and Risk of Gastric Cancer: A Meta-Analysis.
Ye P, Shi Y, Li A. Ye P, et al. Front Physiol. 2018 Apr 17;9:368. doi: 10.3389/fphys.2018.00368. eCollection 2018. Front Physiol. 2018. PMID: 29719511 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous